Prostate cancer screening and the management of clinically localized disease

An unknown affecting prostate cancer treatment decisions for younger patients is knowledge of the range of timescales for the disease to evolve. Molecular-clock techniques have recently determined timescales for the development of pancreatic cancer (Nature v467 p114 2010). Is application of these techniques not a 'future research need' for prostate cancer?